Improving IRBs: A Case Study with Copernicus Group IRB
Does a "Poisonous Fog" Hang Over Clinical Trials for Anti-Depressants?
Clinical Trials Are Slow at Adopting Change
European Medicines Agency Still Struggling with its Accounts
eClinical Immersion, 2
CDER Runs into Trouble with Generic Drug Reorg Plan
Sequestration: How Big a Hit for FDA, Research and Pharma?
Transparency to Alter Sponsor-CRO Relations
ISR Reports Breaks Down: 2013 Late Phase Market Overview and Outlook
The Patient Recruitment Secret (for Sponsors and CROs)
Testing Times for Clinical Trials in Europe
European Commission's proposed system faces scrutiny from three separate committees.
Countdown Time for IMI?
eClinical Immersion
Data Doubts Cloud Europe's Clinical Trials Hopes
What Dedication Looks Like
Small Clinical Trials Feasible for New Limited-Population Approval Pathway
Resolving The Conflict Over Surging Clinical Trial Costs & Sluggish Enrollment
Phase I Trials Take on Greater Budgetary Importance
Bringing Brussels and Africa Closer on Trials
Researchers from sub-Saharan countries are going to have better chances of upgrading their skills.
Are E-Patients Overwhelmed?
2013 - The Year the Clinical Research Industry Adopts Accredited Training?
The Dangers of Media Misreporting Medicines
Medical Translation in Clinical Research
Will "Robust Pipeline" Yield More New Drugs?
An Inside Look at ClinTech 2013
The Gamification of Clinical Trials: What's Next?
Improving Clinical Trial Quality & Productivity at Investigative Sites
ISR's "Social Media: Best Practices and Strategic Use in Patient Recruitment"
Looking Back - and Forward
A Little Light in a Dark Europe
